Flyer 3rd ACHA new - Virology Education...16:45h Managing HCV in HIV infected patients Weiping Cai,...
2
DEAR COLLEAGUE, It is our pleasure to announce the 3rd ACHA (Asian Conference on Hepatitis & AIDS), to be held on 9 - 10 May 2014 at the Peking University in Beijing, China. Over the years, treating viral diseases has become more and more complex. Given the increase in therapeutic options in Asia, clinicians and researchers will benefit from the opportunity to be informed and educated on the newest data and their implications for clinical practice. Simultaneous translation Mandarin - English and dual projection will be available. This workshop aims at bridging the gap between the knowledge that is shared among experts in the field and the knowledge of researchers and clinicians in daily practice. The format of the workshop will consist of a two-day program with invited plenary lectures, round table discussions, abstract presentations, clinical case presentations and poster viewing sessions. In order to stimulate interaction, much time will be allocated for questions and answers. We invite you to join us in Beijing for this extraordinary event and encourage you to submit abstracts on your recent research. INVITATION EXECUTIVE COMMITTEE PROGRAM COMMITTEE 3 RD ASIAN CONFERENCE ON ACHA FROM BASIC SCIENCE TO CLINICAL PRACTICE HEPATITIS&AIDS BEIJING, CHINA • 9-10 MAY 2014 Hui Zhuang, MD Peking University Health Science Centre, China Wei He, MD, PhD Ministry of Health & Peking Union Medical College, China Lai Wei, MD Peking University People’s Hospital, China Jie Li, MD, PhD Peking University Health Center, China Jinlin Hou, MD Nanfang Hospital, Southern Medical University, China Aikichi Iwamoto, MD, DMSci The University of Tokyo, Japan Taisheng Li, MD, PhD Peking Union Medical College Hospital, China Bonaventura Clotet, MD, PhD Hospital Universitari “Germans Trias i Pujol”, Spain Fengmin Lu, MD Peking University Health Center, China Jürgen Rockstroh, MD University of Bonn, Germany Stephen Locarnini, MD, PhD Victorian Infectious Diseases Reference Laboratory, Australia Jonathan Schapiro, MD Sheba Medical Center, Israel Charles Boucher, MD, PhD Erasmus MC, Erasmus University, Netherlands MEETING OBJECTIVES • Education on the best treatment possibilities for Hepatitis B, C and HIV • Sharing cutting-edge information • Presenting latest research • Translating knowledge • Providing a platform for interaction and dialogue • Stimulating discussion among different disciplines • Building collaborations Clinicians, researchers and PhD students active in the field of antiviral therapy. TARGET AUDIENCE
Transcript of Flyer 3rd ACHA new - Virology Education...16:45h Managing HCV in HIV infected patients Weiping Cai,...
DEAR COLLEAGUE,
It is our pleasure to announce the 3rd ACHA (Asian Conference on Hepatitis & AIDS), to be held on 9 - 10 May 2014 at the Peking University in Beijing, China.
Over the years, treating viral diseases has become more and more complex. Given the increase in therapeutic options in Asia, clinicians and researchers will benefit from the opportunity to be informed and educated on the newest data and their implications for clinical practice. Simultaneous translation Mandarin - English and dual projection will be available.
This workshop aims at bridging the gap between the knowledge that is shared among experts in the field and the knowledge of researchers and clinicians in daily practice. The format of the workshop will consist of a two-day program with invited plenary lectures, round table discussions, abstract presentations, clinical case presentations and poster viewing sessions. In order to stimulate interaction, much time will be allocated for questions and answers.
We invite you to join us in Beijing for this extraordinary event and encourage you to submit abstracts on your recent research.
INVITATIONEXECUTIVE COMMITTEE PROGRAM COMMITTEE
3RD ASIAN CONFERENCE ON
ACHAFROM BASIC SCIENCE TO CLINICAL PRACTICEHEPATITIS&AIDSBEIJING, CHINA • 9-10 MAY 2014
Hui Zhuang, MD
Peking University Health Science Centre, China
Wei He, MD, PhD
Ministry of Health & Peking Union Medical College, China
Lai Wei, MD
Peking University People’s Hospital, China
Jie Li, MD, PhD
Peking University Health Center, China
Jinlin Hou, MD
Nanfang Hospital, Southern Medical University, China
Aikichi Iwamoto, MD, DMSci
The University of Tokyo, Japan
Taisheng Li, MD, PhD
Peking Union Medical College Hospital, China
Bonaventura Clotet, MD, PhD
Hospital Universitari “Germans Trias i Pujol”, Spain
Fengmin Lu, MD
Peking University Health Center, China
Jürgen Rockstroh, MD
University of Bonn, Germany
Stephen Locarnini, MD, PhD
Victorian Infectious Diseases Reference Laboratory, Australia
Jonathan Schapiro, MD
Sheba Medical Center, Israel
Charles Boucher, MD, PhD
Erasmus MC, Erasmus University, Netherlands
MEETING OBJECTIVES
• Education on the best treatment possibilities for Hepatitis B, C and HIV
• Sharing cutting-edge information
• Presenting latest research
• Translating knowledge
• Providing a platform for interaction and dialogue
• Stimulating discussion among different disciplines
• Building collaborations
Clinicians, researchers and PhD students active in the field of antiviral therapy.
TARGET AUDIENCE
PROGRAMFRIDAY 9 MAY 2014 08:30h Opening Words
George Gao, DVM, DPhil - Deputy General of CDC, China
HBV Mini-symposium
08:45h What should we do to cure HBVHarry Janssen, MD, PhD - Toronto Western Hospital, Canada
09:15h How to reverse Immune IntoleranceZhigang Tian, MD, PhD - University of Science and Technology
09:45h Cure for HBV - Correlates & DifferencesSharon Lewin, FRACP, PhD - Monash University, Alfred Hospital, Australia
10:15h General Discussion
10:30h Coffee break
Session 1: HIV
11:00h HIV CureSharon Lewin, FRACP, PhD - Monash University, Alfred Hospital, Australia
11:30h HIV co-infections from a European PerspectiveJürgen Rockstroh, MD, PhD - University of Bonn, Germany
12:00h Clinical ImplicationsTaisheng Li, MD, PhD - Peking Union Medical College Hospital, China
12:30h Rationale for starting therapy earlyJonathan Schapiro, MD - Sheba Medical Center, Israel
13:00h General Discussion
13:15h Lunch
14:15h Principles of ResistanceCharles Boucher, MD, PhD - Erasmus MC, Erasmus University, Netherlands
14:45h Treatment Strategies in special populations (women, aging patients, late presenters)Jonathan Schapiro, MD - Sheba Medical Center, Israel
15:15h Case DiscussionsJürgen Rockstroh, MD, PhD - University of Bonn, Germanyand Chinese clinician
16:15h General Discussion
16:30h Adjournment
18:00h Workshop Dinner
SATURDAY 10 MAY 2014 Session 2: HBV
08:30h Has treating HBV reduced Liver Cancer Incidence ?Jinlin Hou, MD - Nanfang Hospital Southern Medical University, China
09:00h How does HBV cause Cancer ? Fengmin Lu, MD - Peking University Health Center, China
09:30h HBV Entry and Receptor General DiscussionWenhui Li, PhD - National Institute of Biological Science, China (tbc)
10:00h General Discussion
10:15h Coffee break
10:45h How to improve early access to treatment CDC representative
11:15h Immune based therapies to cure HBVFusheng Wang, MD, PhD - Beijing 302 Hospital of PLA, China
11:45h General Discussion
12:00h Lunch
Abbvie Lunch Symposium
Session 3: HCV
13:00h Hepatitis C Disease Burden from Asian ProspectiveHui Zhuang, MD - Peking University Health Science Center, China
13:30h DAA’s Role in the USADonald Jensen (tbc)
14:00h DAA’s Role in AsiaLai Wei, MD - Peking University People’s Hospital, China
14:30h IL-28B genotype, to detect or not to detectHuiying Rao, MD, PhD - The People’s Hospital Beijing University, China
15:00h General Discussion
15:15h Coffee break
15:45h Antiviral Therapy in China of HBV/HCV - Clinical PerspectiveJidong Jia, MD, PhD - Beijing friendship Hospital, China
16:15h Clinical management of Hepatitis C patients: to treat or to waitEd Gane (tbc)
16:45h Managing HCV in HIV infected patientsWeiping Cai, MD - Guangzhou ID Hospital, China
17:15h Managing HCV in cirrhotic patients (tbc)Speaker to be identified
17:45h General Discussion
18:00h Closing Remarks and Adjournment
THIS MEETING IS ENDORSED BY: For Chinese text, information and registration: www.virology-education.com
